<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37591624</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>21</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1757-790X</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>8</Issue><PubDate><Year>2023</Year><Month>Aug</Month><Day>17</Day></PubDate></JournalIssue><Title>BMJ case reports</Title><ISOAbbreviation>BMJ Case Rep</ISOAbbreviation></Journal><ArticleTitle>Closure of a distal splenorenal shunt as a therapy for refractory hyperammonaemia in setting of neuropsychiatric symptoms.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e255610</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/bcr-2023-255610</ELocationID><Abstract><AbstractText>Before the widespread use of the transjugular intrahepatic portosystemic shunt, portal hypertension was addressed by the creation of an operative distal splenorenal shunt (DSRS). DSRS was largely regarded as a safe and effective therapy, though it did have a risk of precipitating hyperammonaemia and hepatic encephalopathy.A woman suffered a gunshot wound to the abdomen. This trauma led to portal vein thrombosis, cavernous transformation of the vein and eventually bleeding oesophageal varices from portal hypertension. A DSRS was created to decrease portal hypertension. Years later, she had profound depression with psychomotor slowing in the setting of hyperammonaemia. To reduce hepatic encephalopathy as a contributor to her neuropsychiatric condition, her shunt was closed. The hyperammonaemia resolved and neuropsychiatric symptoms improved.This case highlights several interesting clinical features, including portal hypertension due to chronic portal vein occlusion, cavernous transformation, a surgical DSRS causing hyperammonaemia and hepatic encephalopathy manifesting as neuropsychiatric symptoms.</AbstractText><CopyrightInformation>&#xa9; BMJ Publishing Group Limited 2023. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Miller</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Gastroenterology, Guthrie Robert Packer Hospital, Sayre, PA, USA alexander.miller@guthrie.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bernshteyn</LastName><ForeName>Michelle</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-4457-8165</Identifier><AffiliationInfo><Affiliation>Department of Gastroenterology, Guthrie Robert Packer Hospital, Sayre, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Achakzai</LastName><ForeName>Basit</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Interventional Radiology, Guthrie Robert Packer Hospital, Sayre, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Macfie</LastName><ForeName>Rebekah</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Surgical Oncology, Guthrie Robert Packer Hospital, Sayre, PA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMJ Case Rep</MedlineTA><NlmUniqueID>101526291</NlmUniqueID><ISSNLinking>1757-790X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013164" MajorTopicYN="Y">Splenorenal Shunt, Surgical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006501" MajorTopicYN="Y">Hepatic Encephalopathy</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D022124" MajorTopicYN="Y">Hyperammonemia</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014948" MajorTopicYN="Y">Wounds, Gunshot</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006975" MajorTopicYN="Y">Hypertension, Portal</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Depressive disorder</Keyword><Keyword MajorTopicYN="N">Interventional radiology</Keyword><Keyword MajorTopicYN="N">Liver disease</Keyword></KeywordList><CoiStatement>Competing interests: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>8</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>21</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>18</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>17</Day><Hour>21</Hour><Minute>13</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37591624</ArticleId><ArticleId IdType="pmc">PMC10441096</ArticleId><ArticleId IdType="doi">10.1136/bcr-2023-255610</ArticleId><ArticleId IdType="pii">16/8/e255610</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Saad WE. The history and future of transjugular intrahepatic portosystemic shunt: food for thought. Semin Intervent Radiol 2014;31:258&#x2013;61. 10.1055/s-0034-1382794</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0034-1382794</ArticleId><ArticleId IdType="pmc">PMC4139426</ArticleId><ArticleId IdType="pubmed">25177087</ArticleId></ArticleIdList></Reference><Reference><Citation>Elwood DR, Pomposelli JJ, Pomfret EA, et al. . Distal splenorenal shunt: preferred treatment for recurrent variceal hemorrhage in the patient with well-compensated cirrhosis. Arch Surg 2006;141:385&#x2013;8; 10.1001/archsurg.141.4.385</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archsurg.141.4.385</ArticleId><ArticleId IdType="pubmed">16618897</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiati Kenston SS, Song X, Li Z, et al. . Mechanistic insight, diagnosis, and treatment of ammonia-induced hepatic encephalopathy. Journal of Gastroenterology and Hepatology 2019;34:31&#x2013;9. 10.1111/jgh.14408</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgh.14408</ArticleId><ArticleId IdType="pubmed">30070387</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenkins RL, Gedaly R, Pomposelli JJ, et al. . Distal splenorenal shunt: role, indications, and utility in the era of liver transplantation. Arch Surg 1999;134:416&#x2013;20. 10.1001/archsurg.134.4.416</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archsurg.134.4.416</ArticleId><ArticleId IdType="pubmed">10199316</ArticleId></ArticleIdList></Reference><Reference><Citation>Lynn AM, Singh S, Congly SE, et al. . Embolization of portosystemic shunts for treatment of medically refractory hepatic encephalopathy. Liver Transpl 2016;22:723&#x2013;31. 10.1002/lt.24440</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/lt.24440</ArticleId><ArticleId IdType="pmc">PMC4917293</ArticleId><ArticleId IdType="pubmed">26970243</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanyal AJ, Bosch J, Blei A, et al. . Portal hypertension and its complications. Gastroenterology 2008;134:1715&#x2013;28. 10.1053/j.gastro.2008.03.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2008.03.007</ArticleId><ArticleId IdType="pubmed">18471549</ArticleId></ArticleIdList></Reference><Reference><Citation>Harmanci O, Bayraktar Y. Portal hypertension due to portal venous thrombosis: etiology, clinical outcomes. World J Gastroenterol 2007;13:2535&#x2013;40. 10.3748/wjg.v13.i18.2535</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v13.i18.2535</ArticleId><ArticleId IdType="pmc">PMC4146813</ArticleId><ArticleId IdType="pubmed">17552000</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei B, Huang Z, Tang C. Optimal treatment for patients with cavernous transformation of the portal vein. Front Med (Lausanne) 2022;9:853138. 10.3389/fmed.2022.853138</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.853138</ArticleId><ArticleId IdType="pmc">PMC8987530</ArticleId><ArticleId IdType="pubmed">35402447</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajani R, Bj&#xf6;rnsson E, Bergquist A, et al. . The epidemiology and clinical features of portal vein thrombosis: a multicentre study. Aliment Pharmacol Ther 2010;32:1154&#x2013;62. 10.1111/j.1365-2036.2010.04454.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2036.2010.04454.x</ArticleId><ArticleId IdType="pubmed">21039677</ArticleId></ArticleIdList></Reference><Reference><Citation>Da BL, Koh C, Heller T. Noncirrhotic portal hypertension. Curr Opin Gastroenterol 2018;34:140&#x2013;5. 10.1097/MOG.0000000000000433</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MOG.0000000000000433</ArticleId><ArticleId IdType="pubmed">29465431</ArticleId></ArticleIdList></Reference><Reference><Citation>Grace ND, Conn HO, Resnick RH, et al. . Distal splenorenal vs. portal&#x2010;systemic shunts after hemorrhage from varices: a randomized controlled trial. Hepatology 1988;8:1475&#x2013;81. 10.1002/hep.1840080602</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hep.1840080602</ArticleId><ArticleId IdType="pubmed">3056820</ArticleId></ArticleIdList></Reference><Reference><Citation>Vilstrup H, Amodio P, Bajaj J, et al. . Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the American association for the study of liver diseases and the European association for the study of the liver. Hepatology 2014;60:715&#x2013;35. 10.1002/hep.27210</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hep.27210</ArticleId><ArticleId IdType="pubmed">25042402</ArticleId></ArticleIdList></Reference><Reference><Citation>Odigwe CC, Khatiwada B, Holbrook C, et al. . Noncirrhotic hyperammonemia causing relapsing altered mental status. Baylor University Medical Center Proceedings 2015;28:472&#x2013;4. 10.1080/08998280.2015.11929312</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08998280.2015.11929312</ArticleId><ArticleId IdType="pmc">PMC4569228</ArticleId><ArticleId IdType="pubmed">26424945</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferenci P, Lockwood A, Mullen K, et al. . Hepatic encephalopathy - definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th world congresses of gastroenterology. Hepatology 2002;35:716&#x2013;21. 10.1053/jhep.2002.31250</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/jhep.2002.31250</ArticleId><ArticleId IdType="pubmed">11870389</ArticleId></ArticleIdList></Reference><Reference><Citation>Eftekar M. The association between hepatic encephalopathy/minimal hepatic encephalopathy and depressive and anxiety disorders: a systematic review. Australas Psychiatry 2020;28:61&#x2013;5. 10.1177/1039856219875054</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1039856219875054</ArticleId><ArticleId IdType="pubmed">31868516</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>